However, its effectiveness depends heavily on the delivery method, as standard oral supplements are often poorly absorbed by the digestive system
Semaglutide (Rybelsus) is an oral GLP-1 agonist approved for type 2 diabetes, dosed at 3 mg, 7 mg, or 14 mg daily
Patients should ask specific questions about any proposed treatments: What is the evidence supporting this treatment for my condition
Last but not least, by reducing the dose and avoiding systemic distribution, nasal delivery of GLP-1 drugs should alleviate gastrointestinal and other adverse events, offering a promising approach for maximizing the therapeutic effects GLP-1 drugs with potentially increased compliance and safety
I have been using this for a long time, it is the cleanest and the Glycicnate form is the most effective around
Targeting mitochondrial metabolism for precision medicine in cancer